There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 2 mg | ||
| 5 mg |
| Product Overview | Recombinant Human FLT3LG protein (NP_001191431.1) is produced in Glycoengineered Pichia pastoris. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications. |
| Source | Glycoengineered Pichia pastoris |
| Species | Human |
| Tag | His-Tag, FC-Tag or other Tags as required. |
| Purity | >90% |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | FLT3LG |
| Full Name | Fms-related tyrosine kinase 3 ligand |
| Gene ID | 2323 |
| Uniprot ID | P49771 |
| Accession Number | NP_001191431.1 |
| Background | Dendritic cells (DCs) provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses. FLT3LG controls the development of DCs and is particularly important for plasmacytoid DCs and CD8 (see MIM 186910)-positive classical DCs and their CD103 (ITGAE; MIM 604682)-positive tissue counterparts. |
| Alternate Names | FL; FLG3L; FLT3L |